The mechanism of sodium retention and its location in kidney tubules may vary with time in nephrotic syndrome (NS). We studied the mechanisms of sodium retention in transgenic POD-ATTAC mice, which display an inducible podocyte-specific apoptosis. At day 2 after the induction of NS, the increased abundance of NHE3 and phosphorylated NCC in nephrotic mice compared with controls suggest that early sodium retention occurs mainly in the proximal and distal tubules. At day 3, the abundance of NHE3 normalized, phosphorylated NCC levels decreased, and cleavage and apical localization of γ-ENaC increased in nephrotic mice. These findings indicate that sodium retention shifted from the proximal and distal tubules to the collecting system. Increased cleavage and apical localization of γ-ENaC persisted at day 5 in nephrotic mice when hypovolemia resolved and steady-state was reached.
| INTRODUCTION
The mechanisms of edema formation in nephrotic syndrome (NS) have long been a subject of investigation. 1 The "underfilling" hypothesis postulates that proteinuria and subsequent hypoalbuminemia lead to decreased intravascular oncotic pressure, altering Starling forces and inducing a transfer of water and solutes from plasma into the interstitial space, leading to hypovolemia. The ensuing activation of the Renin-Angiotensin-Aldosterone System (RAAS) results in secondary renal retention of sodium (and therefore water) by activation of ENaC in the connecting tubules and collecting ducts. 2 The "overfilling" hypothesis states that proteinuria itself can cause primary sodium retention via the direct processing and activation of γ-ENaC by urinary serine proteases. 3 Thus, the aldosterone-sensitive distal nephron (ASDN) is thought to be the principal site of sodium retention. Indeed, increased Na,K-ATPase expression and activity have been consistently reported in the cortical collecting duct (CCD) of proteinuric rats. 4 ENaC seems to be a key player in sodium retention in NS, and aldosterone seems to play a permissive role in ENaC activation. The expression and apical targeting of ENaC have been observed to increase in an aldosterone-dependent manner in the CCD of proteinuric rats. 5, 6 Moreover, increased apical ENaC targeting has not been observed in adrenalectomized puromycin aminonucleoside (PAN) nephrotic rats with clamped plasma aldosterone, even when they still displayed amiloride-sensitive sodium retention. 6, 7 The underfilling and overfilling hypotheses are not mutually exclusive since the one or the other mechanism may dominate depending on the development stage of NS, the rate of hypoproteinemia and the absolute plasma oncotic pressure. Current experimental models of NS have severe limitations. Most studies have been conducted in rats injected with toxic substances such as PAN, which induces massive proteinuria and sodium retention but also damages kidney tubules. 6 In addition, knock-out mouse models for podocyte-specific proteins such as nephrin 8 or podocin, 9 which are required for the integrity of the glomerular filtration barrier, display massive perinatal lethality and/or severe renal failure that precludes their utilization as models of idiopathic NS.
In order to circumvent these problems, we used the POD-ATTAC transgenic mouse model, in which NS stems from an inducible podocyte-specific apoptosis, 10 to test our hypothesis that different mechanisms drive sodium retention depending on hemodynamics and the development phase of NS.
| METHODS

| Animal experiments
All animal experiments were approved by the Institutional Ethical Committee of Animal Care of the University of Geneva and Cantonal authorities.
POD-ATTAC transgenic mice kindly provided by Dr. Scherer (Southwestern Texas University, Dallas, TX) were bred and housed in the animal facility of the Faculty of Medicine of Geneva. Genotyping of transgenic mice was performed by PCR analysis of ear biopsies using the following primers: forward, 5′-GAA AGT GCC CAA ACT TCA GAG CAT TAG G -3′ and reverse, 5′ -AAC TGA GAT GTC AGC TCA TAG ATG GGG G -3′. NS was induced by intraperitoneal injection of 0.5 μg/g body weight of the chemical dimerizer, AP20187 (Takara Bio Inc. Kusatsu, Japan), in 8-10 weeks old male transgenic mice. Male wild-type littermates were used as controls and were injected with the same dose of chemical dimerizer.
Mice were individually housed in metabolic cages (Tecniplast, Buguggiate, Italy). Water and food (Provimi-Kliba, Kaiseraugst, Switzerland) containing normal (1.55% wt/wt) or low (0.01% wt/wt) potassium were provided ad libitum. After 1 d of adaptation, food and water intake, body weight, and 24 hours urine volume were recorded daily. Urine was collected each day till day 5 after dimerizer injection for chemical analysis. On the 2 nd , 3 rd , or 5 th day after dimerizer injection, mice were anesthetized by 100 mg/kg ketamine and 5 mg/kg xylazine (Bayer Healthcare, Berlin, Germany). Blood was collected via the submandibular vein for chemical analysis, ascites was weighed on an absorptive tissue after the opening of the peritoneal cavity, and kidneys were removed before sacrifice by lethal bleeding. Kidneys were either fixed by immersion in 4% paraformaldehyde for histological analysis or frozen in liquid nitrogen and stored at -80% for subsequent RNA and protein extraction.
| Biological parameters
Blood parameters (sodium, potassium, chloride, bicarbonate, creatinine, hematocrit) were measured on day 2, 3, or 5 using the Epoc technology (Siemens Healthcare, Erlangen, Germany). Urinary sodium, potassium, chloride, and creatinine concentrations were measured using a UniCel DxC800 Synchron Clinical System automated analyzer (Beckman Coulter, Brea, CA). Plasma and urinary proteins were measured with a Konelab automated analyzer (Thermo-Fisher, Waltham, MA). Results are expressed in mmol/l except protein concentrations, which are expressed in g/L. The urinary protein/creatinine ratio was | 3
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calculated for normalized with respect to the volume of urine excretion. Plasma aldosterone levels were measured according to standard procedures using a radioimmunoassay (Coat-A-Count RIA kit; Siemens Medical Solutions Diagnostics, Ballerup, Denmark). Results are means ± SEM.
| Glomerular filtration rate
Mice were anesthetized with isoflurane and a miniaturized imager device (Mannheim Pharma and Diagnostics, Mannheim, Germany) was mounted onto the animal's back. The skin background signal was recorded for 5 minutes before intravenous injection of 150 mg/kg FITC-sinistrin (Mannheim Pharma and Diagnostics, Germany). Then, transcutaneous fluorescence was recorded for 1h in conscious animals. mGFR (µL/min) was calculated from the decrease in fluorescence intensity over time (ie, plasma half-life of FITCsinistrin) using a two-compartment model, the mouse body weight and an empirical conversion factor using the MPD Lab software (Mannheim Pharma and Diagnostics, Germany), as previously described. 11 Results are means ± SEM.
| Functional diuretic tests
For diuretic response studies, we performed an intraperitoneal injection of hydrochlorothiazide (50 mg/kg) to inhibit NCC or benzamil (5 mg/kg) to inhibit ENaC, as previously described. 12 Urinary Na + excretion was measured 24 hours before and 24 hours after diuretic administration. Results are expressed as a ratio of urinary sodium/urinary creatinine concentrations after or before diuretic administration and as means ± SEM.
| MR antagonist
Potassium canrenoate (Sigma-Aldrich, Saint Louis, MI, USA) was used as a mineralocorticoid receptor (MR) antagonist. POD ATTAC and FVB (Friend leukemia virus B) mice were treated with daily subcutaneous injection of canrenoate (50 mg/kg) starting the day before the injection of the dimerizer, until sacrifice on the 3 rd day after dimerizer injection.
| RNA extraction and real-time qPCR
Total RNA was extracted from kidney and hypothalamus tissues using the NucleoSpin RNA II kit (Macherey-Nagel, Düren, Germany) according to the manufacturer instructions. Five hundred nanograms of RNA were used to synthesize cDNA using the qScript cDNA Supermix (Quantabio, Gaithersburg, MD). Real-time PCR was performed on 10 ng of cDNA using 0.5 mM of each primer, 6 µL of SYBR Green Master Mix (Applied Biosystems) and 2 µL of water to obtain a final reaction volume of 12 µL. The primers used are described in Table 1 . Mouse acidic ribosomal phosphoprotein, P0, was used as the internal standard except where otherwise noted. Duplicate amplification reactions were performed with an ABI prism 7000 Sequence Detection System (Applied Biosystems). Fold difference in cDNA abundance (F) was calculated using the formula F = 2 (Ct1−Ct2) , where Ct1 and Ct2 are the number of cycles required to reach the threshold of amplicon abundance for experimental and control conditions, respectively. Normalization to one control animal was performed to assess biological variability in both controls and nephrotic groups. Results were expressed as fold of control ± SEM.
| Western blotting
Kidney tissues were lysed as previously described. 13 Proteins were quantified using a BCA protein assay kit (Pierce, Rockford, Il), and subjected to SDS-PAGE and blotted onto polyvinylidene difluoride membranes (Immobilon-P; Millipore, Bedford, MA) using standard methods. The antibodies used are indicated in Table 2 . Protein signals were quantified with image J software. Results are expressed as the ratio of the densitometry of the band of interest to the loading control or to the Coomassie blue staining. Then CCA AAC CCT CCG ACT TTC AC CCT TGT GCC TAG CCA GAA GAA normalization to one control animal was also performed to assess biological variability in both controls and nephrotic groups. Results were expressed as fold of control ± SEM. Coomassie blue staining was performed on urine samples in order to detect the proteinuria of POD-ATTAC mice. Each day following dimerizer injection, urine samples from FVB and POD-ATTAC mice were taken, pooled, and diluted (1:20) for comparison to a standard consisting of serial dilutions of bovine serum albumin (BSA). Urine pools and BSA solutions were then denatured by heating for 5 minutes at 95°C and loaded into polyacrylamide gel for SDS-PAGE.
| Immunofluorescence
Paraformaldehyde-fixed kidneys were dehydrated and paraffin-embedded. Kidney sections of 5 µm thickness were used for analysis. Non-specific binding was blocked with normal goat serum 2% for 20 minutes. The sections were incubated with primary antibody (Table 2) (diluted in PBS with 2% BSA) overnight at 4°C and then incubated 1 h with a secondary fluorescent antibody (goat anti-rabbit IgG AlexaFluor 488) at room temperature. Samples were mounted on microscope slides using Vectashield mounting medium (Maravai Life Science, San Diego, CA, USA) with DAPI for nuclear counterstaining. Fluorescence images were acquired using a LSM 710 confocal laser-scanning microscope (Carl Zeiss, Oberkochen, Germany). Z-stack images were summarized using ImageJ software (National institute of Health, US).
| Mathematical modeling of Na + transport along the nephron
Model predictions of transepithelial sodium fluxes and oxygen consumption rates were obtained using a published model of transport along the superficial nephron of a rat. 12, 14 Tubular sodium transport and oxygen consumption rates are expressed in mmol/h/100 g body weight to allow for a direct comparison between rat and mouse data.
| Statistics
Results are given as the mean ± SEM from n independent experiments. Prism version 7.02 (GraphPad Software, San Diego,California,USA) was used for statistical analysis. The normal distribution of the population from which sample data was extracted was determined by a Shapiro-Wilk test. For parametric data, statistical differences were assessed using a two-tailed unpaired t test for comparison between two groups or one-way ANOVA with multipair wise comparison from Tukey for comparisons between more than two groups. For non-parametric data, statistical differences were assessed using the Mann-Whitney test for comparison between two groups or by the Kruskal-Wallis test with a multipair wise comparison from Dunn for comparisons between more than two groups. A P-value <.05 was considered significant.
| RESULTS
| POD-ATTAC mice rapidly developed nephrotic syndrome
After dimerizer injection, POD-ATTAC mice rapidly developed nephrotic proteinuria mainly composed of albumin as detected by Coomassie blue staining ( Figure 1A) . Proteinuria started at day 2 after dimerizer injection, became massive at day 3 and remained stable until at least the 5 th day ( Figure 1B ). In parallel, plasma protein concentration was decreased from days 2 to day 5 ( Figure 1C ). Proteinuria was associated with the development of ascites, decreased natriuresis and weight gain ( Figure 1D ,E, Supplementary Figure 1C ) starting at day 2 and indicated large sodium and fluid retention. Both hematocrit and blood hemoglobin concentration were increased at day 2 and 3 in proteinuric mice as compared to control mice (Table 3) , indicating the contraction of circulating volume at the onset of NS. Ascites was associated with decreased natremia starting at day 2 and becoming significant at day 3. This finding suggests that expansion of extracellular volume was due to both primary sodium and water retention during this early phase ( Figure  1 and Table 3 ). On the 5 th day after dimerizer injection, proteinuria, and hypoproteinemia persisted but hematocrit, hemoglobin, and natremia were normalized when compared to control mice after massive sodium retention and ascites ( Figure 1 and Table 3 ). Finally, POD-ATTAC mice displayed an early and progressive decrease in GFR after the induction of proteinuria, becoming apparent at day 2, maximal at day 3 and remaining stable until day 5 ( Figure 1F ). This decreased GFR was associated with decreased urinary potassium excretion ( Figure 9A ) and hyperkalemia (Table 3 ) starting at day 3 and sustained until day 5.
| Increased expression levels of NHE3 and phosphorylation of NCC are present at the onset of NS
Experiments performed at day 2 after the injection of dimerizer in POD-ATTAC mice revealed an altered expression pattern of nephron segment-specific sodium transporters. The protein abundance of NHE3, a sodium transporter that is mostly expressed along the proximal tubule, was strongly increased in POD-ATTAC mice (percentage of controls ± SEM: 335 ± 65.6) (Figure 2A,B ). In the distal convoluted tubule (DCT), the total NCC protein abundance remained unchanged while phosphorylated NCC levels increased by in nephrotic mice as compared to control mice (percentage of controls ± SEM: 431.2 ± 73.5) (Figure 2A,B ). Immunofluorescence staining showed the apical localization of phosphorylated NCC in both control FVB and POD-ATTAC nephrotic mice ( Figure 2D ). The abundance of NKCC2 protein expressed along the thick ascending limb of Henle (TAL) was not significantly increased and that of β-ENaC and full-length γ-ENaC proteins expressed along the connecting tubule (CNT) and collecting duct (CD) was unchanged. However, α-ENaC protein abundance was significantly decreased and the abundance of the cleaved form of γ-ENaC protein started to rise in POD-ATTAC mice. Figure 2C shows that in contrast to protein levels, the mRNA levels of all the sodium transporters studied remained unchanged in nephrotic mice as compared with control mice indicating that increased NHE3 protein levels are most likely due to decreased protein degradation.
| Decreased NCC phosphorylation and increased γ-ENaC cleavage correlates with massive sodium retention
At day 3 after the injection of dimerizer in POD-ATTAC mice, a different expression pattern of nephron segment-specific sodium transporters was observed. Experiments revealed a massive increase in the cleaved form of γ-ENaC (percentage of controls ± SEM: 403 ± 101.1) associated with a decrease in full-length γ-ENaC abundance (percentage of controls ± SEM: 34 ± 7.7) ( Figure 3A,B) and increased apical staining of γ-ENaC in the CNT and CD ( Figure 3D ) in POD-ATTAC mice. In contrast, the abundance of NCC protein and its phosphorylated form was dramatically decreased during this phase (percentage of controls ± SEM: 52.4 ± 8.1 and 36.6 ± 3 .9 for NCC and phosphorylated NCC respectively) while NHE3 protein abundance returned to baseline levels in nephrotic mice ( Figure 3A,B) . The mRNA levels of NKCC2, NCC, β-, and γ-ENaC were significantly decreased ( Figure 3C ) suggesting a negative feedback on sodium transporters and channels gene transcription or mRNA degradation. 
| Persisting γ-ENaC cleavage at steady state
Western blot analysis and immunohistochemistry experiments performed at day 5 after dimerizer injection revealed a persistent increase in cleaved γ-ENaC abundance (percentage of controls ± SEM: 214.9 ± 25.1) ( Figure 4A ,B) associated with increased apical localization in the principal cells of CNT and CD ( Figure 4D ) in POD-ATTAC mice. This was associated with decreased protein abundance of α-, β-ENaC subunits and full-length γ-ENaC as well as NHE3 and NCC in nephrotic mice (Figure 4A,B) . A persistent decrease in NKCC2, NCC, and β-and γ-ENaC mRNA levels was observed ( Figure 4C ).
| Increased aquaporin 2 abundance
during the early phase of NS Aquaporin 2 (AQP2) accounts for the rate-limiting step of regulated water reabsorption along the CNT and CD. In POD-ATTAC mice, AQP2 protein levels were increased at days 2 (percentage of controls ± SEM: 168 ± 15) and 3 (percentage of controls ± SEM: 177.3 ± 19.7) and returned to control levels at day 5 after dimerizer injection ( Figure 5A,B) . Immunofluorescence staining performed at day 3 showed an increased staining and apical localization of AQP2 in the CD ( Figure 5D ). In addition, after the induction of NS, the mRNA levels of AQP2 were increased at days 2, 3, and 5 whereas hypothalamic vasopressin mRNA levels were unchanged ( Figure 5C ).
| Mathematical simulations predict a shift in sodium transport from PCT to ASDN
The observed changes in sodium transporter abundance at each stage and in GFR were incorporated into a mathematical model of transport along the nephron. Sodium transport ( Figure 6A ) and oxygen consumption ( Figure 6B ) were predicted to increasingly shift toward the CNT and CCD. The model predicted that sodium transport and oxygen consumption decreased both overall and in the PCT at day 2 in nephrotic compared to control mice, despite the upregulation of sodium transporters. This decrease results from the early impairment of the GFR. The predicted decrease in sodium reabsorption and oxygen consumption in the PCT was further pronounced at days 3 and 5 after induction of NS, whereas sodium transport, oxygen consumption and sodium transport efficiency ( Figure 6C ) were predicted to increase in both the CNT and CD. 
| Functional diuretic tests confirmed the shift from NCC-to ENaCdependent sodium retention
We next assessed the function of segment specific sodium transporters by measuring diuretic-induced natriuresis at each day after the induction of glomerular injury. At day 2, the natriuretic response to hydrochlorothiazide, an inhibitor of NCC, and benzamil, an inhibitor of ENaC, were almost equivalent. As expected from Western blotting and immunofluorescence experiments (see Figures  2-4) , the efficiency of benzamil compared to that of hydrochlorothiazide was increased at days 3 and 5 ( Figure 7A ). The ratio of the thiazide-over-benzamil-induced natriuresis (0.8 at day 2, 0.1 at day 3, and 0.3 at day 5) further illustrates this time-dependent shift from NCC-to ENaC-mediated sodium reabsorption in POD-ATTAC mice ( Figure 7B ).
| Sodium retention is independent of a rise in plasma aldosterone levels in nephrotic syndrome
Increased plasma aldosterone (mean ± SEM: 1983 ± 333.1 in POD-ATTAC vs 137 ± 33.4 pg/mL in FVB mice, P = .0009) and SGK1 mRNA levels (fold controls: 3.2) were increased at day 3 after dimerizer injection ( Figure 8A,B) but were similar to control levels at days 2 and 5. This finding suggests that sodium retention observed in POD-ATTAC nephrotic mice at days 2 and 5 was independent of increased plasma aldosterone levels. To further assess the Figure  8E,F) . These findings support the idea that γ-ENaC cleavage and sodium retention are at least partly independent of the transient rise (day 3) in plasma aldosterone levels found in POD-ATTAC mice.
| Low potassium diet prevented hyperkalemia, NCC dephosphorylation and γ-ENaC cleavage at day 3
POD-ATTAC mice were fed a low potassium diet starting from the day of NS induction to prevent hyperkaliemia. Analyses performed at day 3 showed that low potassium-fed nephrotic mice displayed unchanged plasma potassium levels compared to control FVB mice ( Figure 9B ). Western blot analysis at day 3 revealed increased NCC protein abundance and phosphorylation levels associated with decreased abundance of cleaved γ-ENaC compared to normal potassium-fed nephrotic mice. As expected, SPAK protein abundance and phosphorylation levels were increased in low potassium fed control FVB mice but were surprisingly decreased in nephrotic mice fed either a low or normal potassium diet ( Figure  9B,C) . These observations suggest that hyperkaliemia is responsible for the shift from NCC-to ENaC-dependent sodium retention and this occurs independently of SPAK.
| DISCUSSION
In this study, we showed that sodium retention occurs in different nephron segments depending on the stage of development of NS, and that potassium intake has an important role in determining the major tubular site of sodium reabsorption in NS.
| Limitations and advantages of the
POD-ATTAC mouse model
We used the POD-ATTAC mouse model 10 to study the early development and time-course of sodium retention along the nephron. With respect to previous mouse models, POD-ATTAC mice do not display the non-specific tubular and/ or vascular alterations that can be associated with druginduced glomerular injuries. 6 These transgenic mice express a FKBP/caspase-8 fusion protein under the control of the podocin promoter. 10 Activation of endogenous caspase-8 by a chemical dimerizer leads to specific and inducible podocyte apoptosis, massive proteinuria, hypoproteinemia, and ascites. The podocyte specific and dose-dependent apoptosis in POD-ATTAC mice closely mimics human glomerular diseases initiated by podocyte injury such as minimal change disease and focal segmental glomerulosclerosis. 10 Unlike the constitutive knock-out mice models for podocyte-specific proteins like podocin 9 or nephrin, 8 the POD-ATTAC mice display low early mortality, allowing us to study NS from the onset to the steady-state. Moreover, the nephrotic phenotype of POD-ATTAC mice was reproducible between heterozygotes, whereas the inducible inactivation of podocin in mature kidneys led to phenotypic variability concerning the progression of renal disease. 9 However, the POD-ATTAC mice model possesses several limitations: one of them is the early impairment of renal function after the induction of NS that may partly stem from a prerenal dysfunction due to volume contraction and/or an organic renal dysfunction due to the loss of podocytes. The second limitation is the rapid onset of massive proteinuria within 3 d which is similar to the PAN-induced nephrotic model, 3, 4 but more rapid than acquired human diseases.
| Activation of sodium transporters in PCT and DCT during the early phase of nephrotic syndrome
Based on biological parameters we identified three phases in the development of NS in POD-ATTAC mice: the onset of proteinuria occurring at day 2, massive proteinuria and sodium retention occurring at day 3, and the initiation of a steady-state at day 5. At day 2, when nephrotic POD-ATTAC mice displayed hypovolemia associated with proteinuria, we found increased NHE3 protein levels and phosphorylated NCC. These sodium transporters are regulated by the SRAA, which is activated under hypovolemia. NHE3 is up-regulated by the physiological concentration of angiotensin II. 15 A recent work showed that filtered angiotensinogen is reabsorbed by megalin in the PCT in another model of podocyte injury and non-selective proteinuria. 16, 17 Angiotensinogen is then converted into angiotensin II and locally increases NHE3 protein abundance, enhancing sodium reabsorption in the PCT. 16 NCC is also regulated by angiotensin II and aldosterone. 18 In our study, plasma aldosterone abundance were unchanged at day 2 but may exert permissive effects. Moreover, angiotensin II was shown to activate NCC in a WNK (with-no-lysine kinases) 4-dependent manner. 19 The mRNA levels of sodium channels and transporters were unchanged at day 2. This uncoupling between mRNA and protein levels may indicate that observed increases in NHE3 and NKCC2 (although non-significant) protein abundance may rely on increased mRNA translation or decreased protein degradation. The latter is more likely since regulation of protein abundance via modulation of protein degradation rate has been demonstrated for several sodium transporters such as the sodium/ phosphate cotransporter NaPi-2 20 and the Na,K-ATPase. 21 
| Hyperkalemia induces the shift from upstream segments to the ASDN
Three days after the induction of podocyte loss, GFR decreased by 50% and hyperkalemia associated with low kaliuresis, indicating a renal origin, was observed. Results suggest a shift in sodium retention from the PCT and DCT at day 2 to the CNT and CD at day 3, as indicated by the normalized abundance of NHE3, decreased abundance of NCC and phosphorylated NCC, and increased abundance of cleaved γ-ENaC. This shift was prevented by a low potassium diet supporting the hypothesis that potassium homeostasis is a major determinant of the tubular site of sodium reabsorption in NS. Hyperkalemia may promote the decrease in phosphorylated NCC at day 3 in order to increase sodium and fluid delivery to the potassium-secreting segment of the kidney tubule, ie, the DCT2, CNT, and CD. The increased sodium concentration in the fluid delivered to the distal nephron stimulates the entry of sodium through ENaC, thereby augmenting the lumen-negative transepithelial potential that drives the secretion of potassium through ROMK/BK channels. The aldosterone paradox states that the regulation of renal handling of potassium prevails over that of sodium along the kidney tubule. Thus, NCC is inhibited under a large potassium load even when associated with sodium depletion, in order to increase potassium secretion by the distal parts of the nephron. This mechanism is directly mediated by local WNK activity, resulting in the decoupling of NCC and ENaC in ASDN as a first defense against potassium variations. 22 WNK 1, 3, and 4 are expressed in the kidney and are inhibited by high intracellular chloride resulting from high extracellular potassium. The binding of chloride prevents the activation of WNK by autophosphorylation, leading to a SPAK-dependent inhibition of NCC. 23 In FVB control mice fed a low potassium diet, we observed the expected activation of SPAK and NCC. Since plasma potassium did not detectably decrease and underwent little variation, this SPAK activation is likely due to "feed-forward" control of potassium homeostasis ( Figure 10 ). Indeed, "feed-forward" system aims to prevent rises of potassium levels after an oral load, independently of plasma potassium and aldosterone, 24 as opposed to the "feedback" control. Nephrotic POD-ATTAC mice fed a normal potassium diet showed high plasma potassium levels and decreased NCC/SPAK abundance and phosphorylation, as expected. In this case, the "feedback" control of potassium homeostasis may have prevailed since potassium intake was normal ( Figure 10 ). 24 Surprisingly, despite increased protein levels of NCC and phosphorylated NCC, SPAK, and phosphorylated SPAK levels were decreased in nephrotic POD-ATTAC mice fed a low potassium diet. Since urinary potassium excretion was decreased in these mice, plasma potassium did not change compared with control FVB mice. Since extracellular potassium does not change, one can speculate that intracellular chloride and WNK/SPAK activities did not change as well. These results raise the hypothesis of a SPAK-independent activation of NCC.
| γ-ENaC cleavage correlates with massive sodium retention in NS
According to literature, ENaC plays a key role in sodium retention in NS. Our results show that α-and β-subunits were either unchanged or decreased in POD-ATTAC mice, but that cleaved γ-subunit abundance was increased when sodium retention was massive. We have shown previously that overexpressing γ-ENaC in cultured CD principal cells increased ENaC apical expression and activity. 21, 25 We confirmed the importance of the γ-subunit in ENaC activity in our model with diuretic tests that showed the increase in benzamil-induced compared to hydrochlorothiazide-induced natriuresis accompanying the increase in cleaved γ-ENaC. Regulation of γ-ENaC involves its cleavage by proteases in order to increase its open probability and its cell surface expression. 26 Increased cleavage of ENaC subunits associated with decreased mRNA and uncleaved protein levels in POD-ATTAC mice at days 3 and 5 after induction of NS implies a stimulation of the proteolytic maturation of pre-existing ENaC subunits. γ-ENaC may be cleaved by intracellular furin, extracellular membrane-bound proteases like CAP1/prostasin, and soluble proteases. We detected a 75 kDa fragment possibly accompanied by a 70 kDa fragment of γ-ENaC with an antibody reacting with the C-terminal part, which is compatible with furin 27 and CAP1/prostasin 28 cleavage. It has been shown that soluble extracellular proteases present in nephrotic urine may also cleave γ-ENaC in mice and humans. 3 At day 3, nephrotic mice still displayed biological parameters indicative of relative hypovolemia such as increased hematocrit and hemoglobin. Sodium restriction is a strong activator of γ-ENaC cleavage in rats. 29 This process is dependent on aldosterone as evinced by the finding that rats subjected to aldosterone infusion displayed increased cleaved γ-ENaC within 3 hours after the beginning of infusion. The results suggest that aldosterone induces the rapid cleavage and apical addressing of ENaC. 30 Moreover, the cleaved γ-subunit is absent in kidney tubule-specific MR knockout mice. 31 However, the mechanism of γ-ENaC cleavage in NS is still debated.
| Aldosterone-independent regulation of sodium retention
According to the underfilling theory, aldosterone plays a central role in sodium retention because relative hypovolemia is frequently associated with NS, stimulating RAAS and thus aldosterone secretion. However, sodium retention persisted in aldosterone-clamped PAN rats, 5 and sodium retention took place only in the nephrotic kidney in the case of unilateral PAN injection. 32 Furthermore, nephrotic mice displayed high plasma aldosterone and increased mRNA levels of the aldosterone target gene SGK1 at day 3 but normal levels of both were observed when urinary sodium was reduced at day 2. We have also shown that canrenone administration to nephrotic mice did not prevent ascites, weight gain, nor γ-ENaC cleavage at day 3, as previously shown in mice subjected to doxorubicin-induced NS. 33 Those results suggest at least a partial independence of sodium retention from increased plasma aldosterone levels and mineralocorticoid receptor activation. However, aldosterone may participate in the decoupling of NCC and ENaC at day 3 via SGK1, which phosphorylates WNK4 in the DCT thus preventing WNK4-dependent ENaC endocytosis. 34 These results reveal a complex local regulation and interplay between transporters and channels in NS where aldosterone may exert a permissive effect.
| Mechanism of water retention
Apical cell surface expression of AQP2 is rate-limiting for water permeability of the CD. 35 At days 2 and 3, increased AQP-2 mRNA and protein levels together with hyponatremia indicate water retention accompanying sodium retention during the hypovolemic period of NS. Vasopressin is the major controller of AQP2 expression and apical targeting. 36 Surprisingly, at any stage of NS, hypothalamic vasopressin mRNA levels were not increased in nephrotic mice compared to control mice in our study. On one hand, we cannot exclude an early and transient increase in vasopressin mRNA levels. However, vasopressin has a short half-life that makes long lasting effects unlikely. On the other hand, AQP2 protein expression is regulated by other factors which are relevant in our study, such as aldosterone, 37 and interstitial tonicity 38 generated by avid sodium chloride reabsorption. Therefore, the observed increase in AQP2 expression is likely independent of increased vasopressin secretion.
Normalization of plasma sodium concentration and AQP2 protein levels at day 5 contrasted with the persisting increase of AQP2 mRNA levels. Uncoupling between AQP2 protein and mRNA levels in the cortex has been described in certain conditions in rats for instance such as fasting. 39 Nephrotic and control mice displayed similar amounts of water and food intake compared to FVB mice ( Supplementary Figure 1 ), suggesting that another mechanism of uncoupling is at work. Moreover, this observation indicates that the central control of thirst or sodium appetite 40 of hypovolemic nephrotic mice was not a major contributor in the altered sodium and water balance in our study. Our results rather suggest that intrarenal mechanisms are at work to drive massive sodium and water retention.
| CONCLUSIONS
The POD-ATTAC mouse model, despite its limitations, reveals that sodium retention in NS is a continuous process and can occur in different segments of the nephron, depending on hemodynamics, GFR, and plasma potassium. In this model, the underfilling mechanism dominates and potassium balance requirements determine the site of sodium reabsorption in NS. Aldosterone may play a permissive role in the shift from the DCT to ASDN and in the activation of ENaC under conditions of hyperkalemia.
